JPMorgan Chase & Co. reduced its stake in Labcorp Holdings Inc. by 17.6% to 1,074,041 shares, valued at $308.32 million, during Q3 2025. Despite the reduction in holdings, JPMorgan raised its price target for Labcorp to $330 and maintained an “overweight” rating. Labcorp exceeded Q4 2025 EPS estimates with $4.07, and set strong FY2026 EPS guidance, although revenue slightly missed expectations.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
JPMorgan Chase & Co. Has $308.32 Million Holdings in Labcorp Holdings Inc. $LH
JPMorgan Chase & Co. reduced its stake in Labcorp Holdings Inc. by 17.6% to 1,074,041 shares, valued at $308.32 million, during Q3 2025. Despite the reduction in holdings, JPMorgan raised its price target for Labcorp to $330 and maintained an “overweight” rating. Labcorp exceeded Q4 2025 EPS estimates with $4.07, and set strong FY2026 EPS guidance, although revenue slightly missed expectations.